Neuropsychopharmacologia Hungarica

Volume 19, Issue 3, September 2017 [translated version]

In memoriam

In Memoriam Peter Gaszner (1939–2017)

Thomas A. Ban and Andrea Tone

On July 25, 2017, Peter Gaszner, a close friend and a member of our International Network for the History of Neuropsychopharmacology, passed away.

Peter Gaszner was born in 1939, in Bekescsaba, Hungary. He received his MD from the University of Debrecen, Hungary, in 1963, and earned diplomas in neurology, psychiatry and clinical pharmacology in 1957, 1970 and 1980, respectively. He was trained in psychiatry in the Department of Psychiatry at the University of Pecs. During the 1980s, Dr. Gaszner became Director of Psychopharmacology at the National Institute of Neurology and Psychiatry of Hungary and Professor of Psychiatry at Semmelweis University and during the 1990s, he served as Vice President of the European College of Neuropsychopharmacology. Dr. Gaszner was Founding President of the Hungarian Psychopharmacology Society and Founding Editorin-Chief of Neuropsychopharmacologia Hungarica, the journal of the society (Salzman 2011).

All through his professional career Peter was involved in research. In the 1970s his research interest was focused on atropine coma therapy and on epilepsy and anticonvulsants (Ban 2011; Faludi and Ban 2001). In a series of studies conducted in the early 1980s in normal subjects, in collaboration with Elemer Szabadi and Christopher Bradshaw, he demonstrated differences in peripheral anticholinergic activity among tricyclic antidepressants. They had also shown adrenergic blocking effect with neuroleptics (Gaszner, Szabadi and Bradshaw 1980; Szabadi, Gaszner and Bradshaw 1980, 1981). In the 1990s, Dr. Gaszner was a member of the international team which demonstrated the efficacy of reboxetine in major depression (Ban, Gaszner, Aguglia, et al 1998). At the time he was Visiting Professor in our Division of Psychopharmacology at Vanderbilt University, in Nashville we collaborated in developing a Composite Diagnostic Evaluation of Hyperthymic Disorders to study the therapeutic profile of drugs used in the treatment of mania (Gaszner and Ban 1998).

On December 15, 2004, Peter Gaszner (PG) was interviewed by Andrea Tone (AT) at the annual meeting of the American College of Neuropsychopharmacology (ACNP) in San Juan, Puerto Rico. His edited interview (see below) was first printed in volume 8 of ACNP’s Oral History Series (Ban 2011; Salzman 2011).


In memoriam

In memoriam Gaszner Péter (1939–2017)

Thomas A. Ban és Andrea Tone